drugset / Trial / NCT00293761

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00293761

Phase 3 Completed 109 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension

Timeline

Start
2006-01
Primary completion
2006-05
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Travoprost Other / unclassified Topical